Literature DB >> 25584234

Waldenstroms Macroglobulinemia Patient Presenting with Rare 'lytic' Lesions and Hypercalcemia: A Diagnostic Dilemma.

Khalid Mehmood1, Iftikhar Haider Naqvi2, Syed Raza Shah3, Nazia Zakir4, Syed Mustafa Ali5.   

Abstract

Waldenstroms macroglobulinemia (WM) is an uncommon B-cell lymphoproliferative neoplasm characterized by lymphoplasmacytic cells infiltrating the Bone Marrow, along with demonstration of an IgM monoclonal gammopathy in the serum. Lytic lesions are considered one of the basis for differentiating a patient of Multiple Myeloma (MM) and WM. However, very few cases have been reported with a patient presenting with lytic lesions in a WM patient, thereby, complicating the disease. By finding the extent of these lytic lesions and bone involvement, Not only can we signify the presence or absence of bone lesions, but we can also direct the more efficient use of skeletal X-rays for documentation of the extent, location, and response of bone abnormalities to interventional chemotherapy and radiation therapy. Our case was mimicking the classic case of MM. Using the International Criteria for diagnosis for WM, diagnosis for MM was excluded and diagnosis for WM was made. After two weeks of therapy, the patient showed marked clinical improvement.

Entities:  

Keywords:  Lytic lesions; Multiple myeloma; Waldenstroms macroglobulinemia

Year:  2014        PMID: 25584234      PMCID: PMC4290253          DOI: 10.7860/JCDR/2014/8184.5161

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  7 in total

1.  Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005.

Authors:  Sigurdur Y Kristinsson; Sandra Eloranta; Paul W Dickman; Therese M-L Andersson; Ingemar Turesson; Ola Landgren; Magnus Björkholm
Journal:  Am J Hematol       Date:  2012-11-19       Impact factor: 10.047

2.  Immunoglobulin M myeloma: evaluation of molecular features and cytokine expression.

Authors:  Kartik Konduri; Surinder S Sahota; Gavin Babbage; Alex W Tong; Padmasini Kumar; Joseph T Newman; Marvin J Stone
Journal:  Clin Lymphoma       Date:  2005-03

Review 3.  Waldenstrom's macroglobulinemia.

Authors:  M A Dimopoulos; R Alexanian
Journal:  Blood       Date:  1994-03-15       Impact factor: 22.113

4.  Excellent long-term survival of 170 patients with Waldenström's macroglobulinemia treated in private oncology practices and a university hospital.

Authors:  M Hensel; J Brust; C Plöger; D Schuster; M L Memmer; J Franz-Werner; H-P Feustel; A Karcher; S Fuxius; F A Mosthaf; M Rieger; A D Ho; M Witzens-Harig
Journal:  Ann Hematol       Date:  2012-08-16       Impact factor: 3.673

5.  Progression in smoldering Waldenstrom macroglobulinemia: long-term results.

Authors:  Robert A Kyle; Joanne T Benson; Dirk R Larson; Terry M Therneau; Angela Dispenzieri; Shaji Kumar; L Joseph Melton; S Vincent Rajkumar
Journal:  Blood       Date:  2012-03-26       Impact factor: 22.113

6.  Hypercalcaemia due to calcium binding IgM paraprotein in Waldenström's macroglobulinaemia.

Authors:  L Side; M N Fahie-Wilson; M J Mills
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

7.  Parathyroid-hormone-related peptide in hematologic malignancies.

Authors:  R Kremer; C Shustik; T Tabak; V Papavasiliou; D Goltzman
Journal:  Am J Med       Date:  1996-04       Impact factor: 4.965

  7 in total
  4 in total

Review 1.  Controversies in Serotonin Syndrome Diagnosis and Management: A Review.

Authors:  Mohd Faisal Uddin; Richard Alweis; Syed Raza Shah; Noman Lateef; Waqas Shahnawaz; Rohan Kumar Ochani; Amin Muhammad Dharani; Syed Arbab Shah
Journal:  J Clin Diagn Res       Date:  2017-09-01

2.  Management of lytic bone disease in lymphoplasmacytic lymphoma: A case report and review of the literature.

Authors:  Mizba Baksh; Liuyan Jiang; Unnati Bhatia; Victoria Alegria; Taimur Sher; Vivek Roy; Asher Chanan-Khan; Sikander Ailawadhi; Ricardo D Parrondo
Journal:  Clin Case Rep       Date:  2021-12-07

3.  Topical vasodilator response in skeletonized internal mammary artery: Is there really a difference?

Authors:  Syed Raza Shah; Syed Arbab Shah; Muhammad Ahmed Jangda; Mohammad Danial Yaqub; Ayesha Altaf Jangda; Maham Khan; Muhammad Asim Khan; Brian Tomkins
Journal:  Avicenna J Med       Date:  2017 Jan-Mar

4.  Clinical Presentation and Gene Expression Profiling of Immunoglobulin M Multiple Myeloma Compared With Other Myeloma Subtypes and Waldenström Macroglobulinemia.

Authors:  Shebli Atrash; Qing Zhang; Xenofon Papanikolaou; Caleb Stein; Al-Ola Abdallah; Bart Barlogie
Journal:  J Glob Oncol       Date:  2017-05-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.